Login

ITW Olivier Sonneville (DRH CS GROUP) et Marion Langlois (Elles Bougent) par Thomas Hugues | Pierre LOPEZ, Ceo, CS Group SASX:PAR 00:10:00

Share On Facebook Share On Twitter

Pierre LOPEZ is in the postion of Ceo at CS Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
When the Posterior Tonic and Typhoon: An Expert's Perspective
00:10:00
Gary Economou Discusses Focus Graphite’s High-Grade Deposit and Growing Market Demand
00:10:00
DeMarcus Testimonial: Heartland Express Driving in the Northwest | Michael J Gerdin - CHAIRMAN AND CEO of Heartland Express, Inc.
00:10:00
Revolutionizing Telecommunications with Alex West | Alex West, CEO, Swoop Holdings Ltd.
00:10:00
CapMan's Strategic Updates and Ambitious Growth Targets Discussed by CEO Joakim Frimodig | Joakim Frimodig, CEO, CapMan.
00:10:00
Sanlam's Commitment to Transformation and Community Development | Paul Hanratty, CEO , Sanlam Limited.
00:10:00
Sherrese M. Smith, Global Managing Partner, Paul Hastings LLP — Northwestern Law Convocation Keynote 2023 | Sherrese M. Smith - Global Managing Partner of Paul Hastings
00:10:00
Canopy Growth CEO Discusses Market Expansion and Profitability Outlook| David Klein, CEO, Canopy Growth Corp.
00:10:00
Veon CEO Kaan Terzioğlu discusses the company's transformation into a more streamlined entity following its exit from Russia.
00:10:00
Understanding Mormonism: History, Beliefs, and the Book of Mormon|Richard Bushman,Professor,Columbia University
00:10:00
Examining the Current Credit Landscape with Oak Hill Advisors |Glenn August , CEO, Oak Hill Advisors.
00:10:00
Cramer interviewed Bill Staples, CEO of New Relic, during a CNBC Investing Club session.

© 2017 - Neuhu+